|
HJURP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.209400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.137800E-01 |
| Normal-vs-Stage2 |
1.464580E-01 |
| Normal-vs-Stage3 |
9.135400E-01 |
| Normal-vs-Stage4 |
7.962000E-01 |
| Stage1-vs-Stage2 |
7.61000000000234E-05 |
| Stage1-vs-Stage3 |
6.272400E-01 |
| Stage1-vs-Stage4 |
7.621000E-01 |
| Stage2-vs-Stage3 |
7.281900E-03 |
| Stage2-vs-Stage4 |
6.475400E-03 |
| Stage3-vs-Stage4 |
5.626200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.199600E-01 |
| Normal-vs-AfricanAmerican |
5.557400E-01 |
| Normal-vs-Asian |
9.816000E-01 |
| Caucasian-vs-AfricanAmerican |
3.366800E-01 |
| Caucasian-vs-Asian |
8.819800E-01 |
| AfricanAmerican-vs-Asian |
3.654600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.933600E-01 |
| Normal-vs-Female |
8.134000E-01 |
| Male-vs-Female |
2.044000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.267400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.518200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.484600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.259010E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.031050E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.871960E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.246000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.506850E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.874000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.549380E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.770600E-01 |
| Classical-VS-Follicular |
5.040200E-04 |
| Classical-VS-Other |
5.494200E-02 |
| Classical-VS-Normal |
8.360000E-01 |
| Tall-VS-Follicular |
4.843900E-02 |
| Tall-VS-Other |
1.501770E-01 |
| Tall-VS-Normal |
7.337000E-01 |
| Follicular-VS-Other |
5.015800E-01 |
| Follicular-VS-Normal |
2.400000E-01 |
| Other-VS-Normal |
4.343200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.041800E-01 |
| Normal-vs-N1 |
8.126600E-01 |
| N0-vs-N1 |
7.647200E-01 |
|
|
